Senti Biosciences Announces New Employment Inducement Grants

February 3, 2023

https://www.globenewswire.com/news-release/2023/02/03/2601626/0/en/Senti-Biosciences-Announces-New-Employment-Inducement-Grants.html

SOUTH SAN FRANCISCO, Calif., Feb. 03, 2023 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq:SNTI) (“Senti Bio”), a biotechnology company innovating next-generation cell and gene therapies using its proprietary Gene Circuit technology platform, today announced that effective on February 1, 2023, the Compensation Committee of Senti Bio’s Board of Directors granted to 13 new employees stock options to purchase an aggregate of 309,000 shares of the Company’s common stock with a per share exercise price of $1.81. These awards were made under the Company’s 2022 Inducement Equity Plan (the Plan).

Read more at globenewswire.com

Related news for (SNTI)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.